Surmodics | SRDX - SCHULD





SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Align Technology USD 114.45M 6.82M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Artivion USD 317.78M 619K 2024-12
Baxter International USD 9.78B 68M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
EDAP TMS EUR 7.55M 1.41M 2025-09
Edwards Lifesciences USD 600M 105.4M 2026-03
Haemonetics USD 1.22B 54K 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
J&J USD 47.93B 2.14B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Mesa Laboratories USD 204.98M 7.27M 2024-09
Nektar Therapeutics USD 0 0 2022-06
Option Care Health USD 1.15B 1.01M 2026-03
Stryker USD 14.22B 635M 2026-03
Surmodics USD 29.55M 111K 2024-09
Trinity Biotech USD 100.76M 7.05M 2024-12